Trexquant Investment LP increased its position in shares of Trupanion, Inc. (NASDAQ:TRUP - Free Report) by 89.2% in the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund owned 261,246 shares of the financial services provider's stock after purchasing an additional 123,137 shares during the quarter. Trexquant Investment LP owned 0.61% of Trupanion worth $9,737,000 as of its most recent filing with the SEC.
A number of other institutional investors and hedge funds have also recently bought and sold shares of TRUP. Jump Financial LLC raised its stake in Trupanion by 27.5% during the first quarter. Jump Financial LLC now owns 87,673 shares of the financial services provider's stock worth $3,268,000 after purchasing an additional 18,919 shares during the period. Palisade Capital Management LP lifted its holdings in Trupanion by 36.7% in the 1st quarter. Palisade Capital Management LP now owns 244,354 shares of the financial services provider's stock worth $9,107,000 after buying an additional 65,653 shares in the last quarter. Dimensional Fund Advisors LP increased its holdings in Trupanion by 112.2% during the 4th quarter. Dimensional Fund Advisors LP now owns 273,910 shares of the financial services provider's stock worth $13,204,000 after purchasing an additional 144,828 shares during the last quarter. Russell Investments Group Ltd. grew its holdings in shares of Trupanion by 277.7% during the first quarter. Russell Investments Group Ltd. now owns 34,643 shares of the financial services provider's stock valued at $1,291,000 after purchasing an additional 25,471 shares during the last quarter. Finally, Northern Trust Corp grew its position in shares of Trupanion by 9.0% during the fourth quarter. Northern Trust Corp now owns 368,236 shares of the financial services provider's stock worth $17,749,000 after acquiring an additional 30,549 shares during the last quarter.
Trupanion Stock Performance
Shares of TRUP traded up $0.37 during mid-day trading on Thursday, hitting $44.55. 132,112 shares of the company's stock were exchanged, compared to its average volume of 593,081. The company has a quick ratio of 1.69, a current ratio of 1.69 and a debt-to-equity ratio of 0.32. Trupanion, Inc. has a 52 week low of $31.00 and a 52 week high of $57.90. The firm has a market cap of $1.92 billion, a price-to-earnings ratio of 171.33 and a beta of 1.72. The stock's 50-day simple moving average is $49.45 and its 200-day simple moving average is $44.02.
Trupanion (NASDAQ:TRUP - Get Free Report) last released its quarterly earnings data on Thursday, August 7th. The financial services provider reported $0.22 earnings per share for the quarter, beating the consensus estimate of ($0.03) by $0.25. The business had revenue of $353.56 million for the quarter, compared to analyst estimates of $346.73 million. Trupanion had a return on equity of 3.31% and a net margin of 0.81%.Trupanion's revenue was up 12.3% compared to the same quarter last year. During the same period last year, the firm posted ($0.14) earnings per share. Trupanion has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. On average, equities research analysts expect that Trupanion, Inc. will post 0.13 EPS for the current year.
Insider Activity at Trupanion
In other Trupanion news, CFO Fawwad Qureshi sold 2,800 shares of the company's stock in a transaction dated Tuesday, August 26th. The shares were sold at an average price of $45.56, for a total value of $127,568.00. Following the completion of the sale, the chief financial officer directly owned 6,451 shares of the company's stock, valued at approximately $293,907.56. This represents a 30.27% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. 5.42% of the stock is currently owned by company insiders.
Wall Street Analysts Forecast Growth
Several equities analysts have recently weighed in on TRUP shares. Stifel Nicolaus raised their price objective on shares of Trupanion from $41.00 to $45.00 and gave the company a "hold" rating in a research report on Friday, August 8th. Cantor Fitzgerald upgraded shares of Trupanion to a "hold" rating in a research report on Wednesday, August 13th. Finally, Piper Sandler upped their target price on shares of Trupanion from $62.00 to $67.00 and gave the stock an "overweight" rating in a report on Friday, August 8th. Three research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to MarketBeat, Trupanion currently has a consensus rating of "Moderate Buy" and an average price target of $54.17.
Get Our Latest Stock Analysis on TRUP
Trupanion Profile
(
Free Report)
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.
Read More

Before you consider Trupanion, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Trupanion wasn't on the list.
While Trupanion currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.